lobbying_activities: 3242491

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3242491	23cc99e2-d1b0-40f4-8fb8-f96c9d1789c5	Q3	AMERICAN CLINICAL LABORATORY ASSN	1923	AMERICAN CLINICAL LABORATORY ASSN	2024	third_quarter	MED	Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, test coding and pricing, coverage, and payment, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); FDA and CMS policies related to diagnostics and laboratory regulation; FY 2024 budget and appropriations processes, artificial intelligence in laboratory services; public-private sector testing response in general and specific to Influenza A (H5) avian flu, monkeypox and oropouche; H.R. 2377/S. 1000, Saving Access to Laboratory Services Act; H.R. 8818, American Privacy Rights Act of 2024; H.R. 8702/S. 4532, Improving Seniors Timely Access to Care Act; and H.R. 2369, the Verifying Accurate Leading-edge IVCT Development Act (VALID Act) of 2023.	Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Security Council (NSC),SENATE,White House Office		540000	0	0	2024-10-17T11:00:12-04:00